Intravascular Lithotripsy in High Risk Calcified Iliac Anatomy for Transfemoral TAVR
NCT: NCT05862558 · RECRUITING
Brief Summary
To assess the efficacy and safety of Intravascular Lithotripsy (IVL) in subjects undergoing transfemoral TAVR in patients with severe iliac disease, prohibitive for transfemoral TAVR in patients with severe symptomatic aortic stenosis, otherwise considered for alternative access TAVR. (e.g. trans-carotid)
Frequently Asked Questions
What is Intravascular Lithotripsy in High Risk Calcified Iliac Anatomy for Transfemoral TAVR?
Intravascular Lithotripsy in High Risk Calcified Iliac Anatomy for Transfemoral TAVR is a clinical trial registered under NCT05862558. Current status: RECRUITING.
What is the status of NCT05862558?
The current status of NCT05862558 (Intravascular Lithotripsy in High Risk Calcified Iliac Anatomy for Transfemoral TAVR) is: RECRUITING.
When did Intravascular Lithotripsy in High Risk Calcified Iliac Anatomy for Transfemoral TAVR start?
Intravascular Lithotripsy in High Risk Calcified Iliac Anatomy for Transfemoral TAVR started on 2023-03-30.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.